Doheny Eye Institute

Around the world, eye disease afflicts millions of people whose lives and potential are diminished by partial or total loss of sight. For 75 years, Doheny Eye Institute has been at the forefront of the battle against eye disease by providing state-of-the-art clinical services, supporting leading researchers in finding cutting edge treatment and cures and educating the future leaders of ophthalmology

The Doheny Eye Institute enjoys an international reputation among leading ophthalmologists as a premier institution. Doheny is able to capitalize on its reputation by recruiting the best in the field and training tomorrow's leaders in ophthalmology.

A key resource available to Doheny scientists is the group of specialized core laboratories, which provide equipment and expertise that researchers could not afford individually. These shared facilities include a tissue culture laboratory where tissues are sorted, prepared and preserved for study; a histopathology and immunology service providing tissue processing, staining and embedding of tissues into slides for research and teaching purposes; multi-million dollar microscopes for imaging tissues and cells; and a biostatistics module which aids scientists in the design of studies and analysis of data. Experienced technicians assist and train researchers in the use of laboratory equipment and processes.

Decades of success in pioneering research and creating healthy change have established Doheny Eye Institute as one of the world's premier institutions on the front lines of both fighting eye disease and preventing of loss of vision. Our Doheny Image Reading Center is uniquely equipped to enhance the value and utility of ophthalmic image interpretation in both clinical and research applications. This center provides tools to precisely characterize and quantify diseases of the eye with the latest imaging technology for addressing retinal disease. With our historic alliance with UCLA and its world-class Stein Eye Institute, we are poised to realize more positive results than ever before. Our complementary research and clinical services mean that thousands more can benefit from the synergy and joint resources of these two world-class institutions.

As the Doheny Eye Institute is committed to extending diagnositc and clinical services, our board of directors has negotiated an historic strategic alliance with UCLA and Stein Eye Institute, another renowned institution for ophthalmic care with services that complement our own.

This partnership will secure the future of state-of-the-art ophthalmic care, treatment and research. The timing is critical, as the need for our services and research continues to grow. One example: age-related macular degeneration (AMD) affects more than 2 million Americans over the age of 50. By 2020, an additional 2.95 million are expected to be diagnosed with the disease. Doheny Eye Institute is one of the world's leading centers for new treatments for AMD. Doheny researchers have contributed to major studies of wet AMD therapies. They continue to perfect minimally invasive surgical procedures for wet AMD treatment, while leading the country's most advanced center for imaging in support of AMD clinical trials.